Results 131 to 140 of about 57,995 (263)

18F-AlF-NOTA-octreotide PET/CT and 3D printing technology for precision diagnosis and treatment of phosphaturic mesenchymal tumors in patients with tumor-induced osteomalacia: two case reports

Frontiers in Endocrinology
ObjectiveThis study aims to report the application of 18F-AlF-NOTA-Octreotide PET/CT and 3D printing technology in the diagnosis and treatment of phosphaturic mesenchymal tumors (PMT) in patients with tumor-induced osteomalacia (TIO).Case presentationA ...
Gang Zhao, Lijuan Guan, Yongqiang Zhang, Xingzhen Shi, Wenming Luo, Maiqing Yang, Qi Wang, Zhen Liu, Yongqiang Liu, Xiaolei Ding, Jie Zhao   +10 more
doaj   +1 more source

Dataset related to article "Direct effects of octreotide on osteoblast cell proliferation and function"

, 2022
Eleonora Vitali, Eleonora Palagano, Maria Lucia Schiavone, Giovanna Mantovani, Cristina Sobacchi, Gherardo Mazziotti, Andrea Lania   +6 more
openalex   +1 more source

Expression Analysis of Dopamine Receptor Subtypes in Normal Human Pituitaries, Nonfunctioning Pituitary Adenomas and Somatotropinomas, and the Association between Dopamine and Somatostatin Receptors with Clinical Response to Octreotide-LAR in Acromegaly [PDF]

, 2009
Leonardo Vieira Neto, Ednildo A. Machado, Raúl M. Luque, Giselle Fernandes Taboada, Jorge B Marcondes, Leila Chimelli, Leonardo Pereira Quintella, Paulo Niemeyer, Denise Pires de Carvalho, Rhonda D. Kineman, Mônica R. Gadelha   +10 more
openalex   +1 more source

Comparison of 177Lu-octreotate and 177Lu-octreotide for treatment in human neuroblastoma-bearing mice

Heliyon
Background: Patients with high-risk neuroblastoma (NB) have a 5-year event-free survival of less than 50 %, and novel and improved treatment options are needed. Radiolabeled somatostatin analogs (SSTAs) could be a treatment option.
A. Romiani, K. Simonsson, D. Pettersson, A. Al-Awar, N. Rassol, H. Bakr, D.E. Lind, G. Umapathy, J. Spetz, R.H. Palmer, B. Hallberg, K. Helou, E. Forssell-Aronsson   +12 more
doaj   +1 more source

Efficacy of long-acting release octreotide for preventing chemotherapy-induced diarrhoea: protocol for a systematic review [PDF]

, 2017
Chao Deng, Bo Deng, Liqun Jia, Huangying Tan   +3 more
openalex   +1 more source

A Case of Dermatomyositis and Anti-EJ Autoantibody with Chronic Intestinal Pseudoobstruction Successfully Treated with Octreotide

Case Reports in Rheumatology, 2016
Chronic intestinal pseudoobstruction (CIPO) is a serious complication in patients with connective tissue disease (CTD) and is sometimes life-threatening or fatal despite intensive medical treatment. Here, we report a patient with dermatomyositis (DM) and
Chiho Yamada, Shinji Sato, Noriko Sasaki, Takayoshi Kurabayashi, Sho Sasaki, Yasushi Koyama, Naofumi Chinen, Takayuki Wakabayashi, Yasuo Suzuki   +8 more
doaj   +1 more source

Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy. [PDF]

, 2016
BackgroundEverolimus, an oral mammalian target of rapamycin (mTOR) inhibitor, is used to treat solid tumors and tuberous sclerosis complex (TSC). Stomatitis, an inflammation of the mucous membranes of the mouth, is a common adverse event associated with ...
Anak, O, Franz, D, Gallo, J, Hortobagyi, GN, Motzer, R, Pavel, M, Ravaud, A, Ringeisen, F, Rouyrre, N, Rugo, HS, Yao, J   +10 more
core  

99mTc-Octreotide Uptake in the Uterus and a Subserosal Myoma Mimicking Tumoral Masses [PDF]

, 2014
Elahe Pirayesh, Mahasti Amoui, Majid Assadi   +2 more
openalex   +1 more source

Gall stones induced by octreotide. [PDF]

, 1992
S M Catnach, J. A. H. Wass, J. V. Anderson, Martin Besser, P D Fairclough, Hina Syeda Hussaini, Harry F. Dowling   +6 more
openalex   +1 more source

Evaluation of radiological and clinical efficacy of ^{90}Y-DOTATATE} therapy in patients with progressive metastatic midgut neuroendocrine carcinomas [PDF]

, 2009
Background: To evaluate the radiological and clinical therapeutic effectiveness of ^{90}Y-octreotate [DOTATATE] inpatients with progressive somatostatin receptor-positive midgut neuroendocrine carcinomas (GEPNETs).
Buscombe, John R., Cwikła, Jaroslaw B., Jeziorski, Krzysztof G., Mikolajczak, Renata, Nasierowska-Guttmejer, Anna, Pawlak, Dariusz, Sankowski, Artur, Walecki, Jerzy   +7 more
core